Medicared For All Logo

Sharon Goble in Midlothian, Virginia

Home Virginia Midlothian

Sharon Goble has Hematology/oncology as her primary medical specialty. Their primary office is: 6130 Harbourside Centre Loop in Midlothian, Virginia. There is an additional office location, for a total of two, for Sharon Goble that can be viewed further down.

They're a part of the: Virginia Cancer Institute Incorporated medical group which has around 41 members. You can call their office at 804-378-0394 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Virginia Commonwealth University, School Of Medicine and graduated in 1997 (around 27 years of experience). They are listed as doing telehealth appointments.


Sharon A Goble Office Phone and Directions

Sharon Goble
Virginia Cancer Institute Incorporated
6130 Harbourside Centre Loop
Midlothian, Virginia 23112
804-378-0394


Patient Ratings
Please rate your experience with Sharon Goble below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 804-378-0394


Enter a starting address:


Healthcare Info for Sharon Goble

Medical School: Virginia Commonwealth University, School Of Medicine
Graduation Year: 1997
The Primary Medical Specialty for Sharon Goble is listed as: Hematology/oncology
Approximate Years of Experience: 27
PAC (PECOS ID)#: 7315027927
NPI #: 1255394417
NPI Created On: 04/10/2006
NPI Last Updated Listed as: 05/21/2021
Primary Taxonomy Code: 207RH0003X
License Number:
0101057936
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Optima Health Plan
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Flow cytometry technique for dna or cell analysis
  2. Flow cytometry technique for dna or cell analysis
  3. Hydration infusion into a vein 31 minutes to 1 hour
  4. Hydration infusion into a vein
  5. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  6. Infusion into a vein for therapy, prevention, or diagnosis
  7. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  8. Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
  9. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  10. Injection of drug or substance into a vein for therapy, diagnosis, or prevention
  11. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  12. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
  13. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
  14. Infusion of chemotherapy into a vein using push technique
  15. Infusion of different chemotherapy drug or substance into a vein
  16. Infusion of chemotherapy into a vein up to 1 hour
  17. Infusion of chemotherapy into a vein
  18. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  19. Irrigation of implanted venous access drug delivery device
  20. Therapeutic removal of whole blood to correct blood level imbalance

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2779933;EPRINTS;10227062

Record ID:: 845873419

Being Disputed:: No

Product Related: Yes


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 845594863

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HEMATOLOGY/ONCOLOGY

Name of Drug #1: ZEPZELCA

Open Associated Drug #1: 68727-712-01

Drug or Biological: Drug

Product Category #2: HEMATOLOGY/ONCOLOGY

Name Of Drug #2:: VYXEOS

Associated Drug #2: 68727-745-01


Additional Office Locations

1. Virginia Cancer Institute Incorporated
1401 Johnston Willis Dr
North Chesterfield, VA 23235
Suite 100
Group Members: 41

Phone: 804-378-0394

Enter a starting address:


Hematology/oncology Professionals in Midlothian

6130 Harbourside Centre Loop
Midlothian, VA
Virginia Cancer Institute Incorporated

14051 St Francis Blvd
Midlothian, VA
Bon Secours-richmond Community Hospital Llc

6130 Harbourside Centre Loop
Midlothian, VA
Virginia Cancer Institute Incorporated

Providers in Virginia Cancer Institute Incorporated

1.Emily Bellavance

10710 Midlothian Tpke
North Chesterfield Va 23235-4766
Virginia Cancer Institute Incorporated
General Surgery

2.Emily Bellavance

4730 Puddledock Rd
Prince George Va 23875-1274
Virginia Cancer Institute Incorporated
General Surgery

3.Christine Bouchard

10710 Midlothian Tpke
North Chesterfield Va 23235-4766
Virginia Cancer Institute Incorporated
Colorectal Surgery (proctology)

4.Yuvraj Choudhary

1401 Johnston Willis Dr
North Chesterfield Va 23235-4730
Virginia Cancer Institute Incorporated
Hematology/oncology

5.Joseph Evers

7501 Right Flank Rd
Mechanicsville Va 23116-3863
Virginia Cancer Institute Incorporated
Hematology/oncology

6.Joseph Evers

8007 Discovery Dr
Richmond Va 23229-8605
Virginia Cancer Institute Incorporated
Hematology/oncology

View all 41 members of Virginia Cancer Institute Incorporated medical group